tsh biopharmoration Ltd

8432 · TWO · Healthcare / Drug Manufacturers - Specialty & Generic

61.30TWD+0.10 (+0.16%)

Price History

Full chart

Market Stats

Previous Close61.20

Open61.00

Day Range60.60 – 61.50

52-Week Range48.60 – 59.30

Volume93.42K

Market Cap1.96B

P/E (TTM)11.75

Forward P/E19.61

EPS4.35

Dividend Yield5.11%

Beta0.31

50-Day Avg50.35

200-Day Avg52.20

About

TSH Biopharm Corporation Limited develops and markets pharmaceutical products in Taiwan. The company offers prescription medication for cardiovascular, central nervous, gastrointestinal, and others. It also provides MPap, a methylation-specific qPCR technology to detect the methylation status of CDO1 and BHLHE22 genes using cervical scraping; AlphaLiquid Detect, a hybrid capture NGS-based liquid biopsy test designed for MRD detection and surveillance in stage I-III solid tumor patients; AlphaLiquid 100, a liquid biopsy test designed for patients with advanced solid cancers; AlphaLiquid HRR, AlphaSolid, and AlphaSolid HRR, a tissue biopsy test designed for patients with advanced solid cancers. The company was founded in 2000 and is headquartered in Taipei, Taiwan. TSH Biopharm Corporation Limited operates as a subsidiary of TTY Biopharm Company Limited.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMs. Sze-Yuan Yang
Employees0
HeadquartersNo. 3-1 Yuanqu Street, Taipei, Taiwan, 11503, Taiwan
Websitehttps://www.tshbiopharm.com

Leadership

Ms. Sze-Yuan YangPresident
Mr. Jung-Liang KaoSenior Division Director of Finance Division & CFO
Ms. Chen-Ju KanSenior Manager of the Accounting Department
Mr. Yu-Chung WuSenior Director of Sales
Mr. Chuan-Hsu ChenSenior Director of Marketing
Mr. Hsin-Young LiuCompany Secretary

Financials

Income Statement

Currency: TWD	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	486.28M	515.65M	507.67M	447.86M	413.48M	741.07M	810.92M	1.12B	1.34B
Growth (%)	-	+6.04%	-1.55%	-11.78%	-7.68%	+79.23%	+9.43%	+37.59%	+19.79%
Cost of Revenue	168.97M	181.26M	192.94M	162.67M	166.13M	351.20M	411.02M	532.95M	655.78M
Gross Profit	317.31M	334.39M	314.73M	285.19M	247.36M	389.87M	399.90M	582.76M	680.74M
Gross Margin	65.25%	64.85%	62.00%	63.68%	59.82%	52.61%	49.31%	52.23%	50.93%
Operating Expense	246.39M	278.28M	258.53M	208.04M	185.83M	304.89M	325.05M	412.14M	461.47M
Operating Income	70.92M	56.11M	56.20M	77.16M	61.53M	84.98M	74.84M	170.62M	219.27M
Operating Margin	14.58%	10.88%	11.07%	17.23%	14.88%	11.47%	9.23%	15.29%	16.41%
EBITDA	76.84M	61.73M	113.05M	86.81M	71.31M	106.51M	97.42M	202.84M	262.32M
EBITDA Margin	15.80%	11.97%	22.27%	19.38%	17.25%	14.37%	12.01%	18.18%	19.63%
Net Income	64.97M	57.78M	85.33M	61.57M	47.11M	61.89M	61.99M	113.09M	139.26M
Net Income Margin	13.36%	11.21%	16.81%	13.75%	11.39%	8.35%	7.64%	10.14%	10.42%
R&D	74.43M	96.77M	52.78M	28.68M	23.52M	31.09M	24.81M	27.99M	24.61M
R&D as % of Total Revenue	15.31%	18.77%	10.40%	6.40%	5.69%	4.20%	3.06%	2.51%	1.84%
Interest Expense	0	0	82.00K	27.00K	80.00K	699.00K	688.00K	456.00K	797.00K
Interest Expense % of Total Revenue	0.00%	0.00%	0.02%	0.01%	0.02%	0.09%	0.08%	0.04%	0.06%

Balance Sheet

Currency: TWD	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	1.28B	1.22B	1.26B	1.23B	1.17B	1.44B	1.40B	1.84B	1.95B
Total Liabilities	135.08M	99.44M	138.79M	103.04M	85.80M	222.46M	133.63M	219.22M	233.79M
Total Equity	1.15B	1.12B	1.12B	1.13B	1.08B	1.14B	1.11B	1.39B	1.44B
Cash	394.64M	216.37M	224.21M	396.70M	381.89M	488.90M	576.59M	588.34M	464.54M
Total Debt	-	-	-	10.25M	5.01M	63.86M	7.84M	-	-
Net Debt	-	-	-	-386.45M	-376.88M	-425.05M	-568.74M	-	-

Cash Flow

Currency: TWD	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	81.13M	62.62M	88.65M	11.61M	68.71M	34.35M	33.87M	183.77M	139.52M
Investing Cash Flow	109.71M	-160.25M	-15.00M	234.21M	-10.06M	10.86M	-	-	-
Financing Cash Flow	-119.03M	-80.64M	-65.81M	-73.33M	-73.46M	-89.40M	-107.18M	-	-
Capital Expenditure	4.57M	5.88M	3.00M	2.38M	382.00K	18.73M	5.56M	2.74M	10.40M
Free Cash Flow	76.56M	56.64M	85.51M	9.23M	68.33M	15.62M	28.32M	181.03M	129.12M
Dividends Paid	119.03M	80.64M	61.44M	69.12M	69.12M	57.60M	61.44M	49.15M	81.40M
FCF to OCF	94.37%	90.45%	96.46%	79.51%	99.44%	45.48%	83.59%	98.51%	92.54%
Dividend Paid to FCF	155.48%	142.37%	71.85%	748.67%	101.16%	368.67%	216.98%	27.15%	63.05%

Earnings

Report Date	May 30, 2012	Aug 29, 2012	Oct 25, 2012	Mar 18, 2013	May 29, 2013	Aug 14, 2013	Nov 12, 2013	Mar 26, 2014	May 11, 2014	Aug 12, 2014	Nov 13, 2014	Mar 30, 2015	Apr 15, 2015	Jul 15, 2015	Nov 13, 2015	Mar 29, 2016	Jun 1, 2016	Aug 31, 2016	Nov 9, 2016	Mar 1, 2017	May 31, 2017	Aug 14, 2017	Nov 13, 2017	Mar 29, 2018	May 10, 2018	Aug 13, 2018	Nov 13, 2018	Mar 27, 2019	May 13, 2019	Aug 11, 2019	Oct 31, 2019	Mar 24, 2020	Jun 3, 2020	Sep 2, 2020	Nov 11, 2020	Mar 3, 2021	Jun 2, 2021	Sep 1, 2021	Nov 10, 2021	Mar 2, 2022	May 3, 2022	Aug 2, 2022	Nov 2, 2022	Mar 3, 2023	May 3, 2023
EPS Estimate	-	-	1.21	0.85	-	-	-	-	-	-	-	-	0.45	0.48	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.30	0.67	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	1.35	0.80	0.86	0.87	0.86	0.96	0.67	0.37	0.71	0.78	0.24	0.21	0.32	0.65	0.35	0.83	1.46	1.94	0.06	0.20	0.33	0.49	0.48	0.39	0.86	0.16	0.24	0.24	0.66	0.22	1.20	0.14	0.62	0.21	0.40	0.37	0.25	0.34	0.26	0.38	0.51	0.42	0.47	0.21	0.28
Surprise	-	-	-28.93%	2.35%	-	-	-	-	-	-	-	-	-28.89%	35.42%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-26.67%	79.10%	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	After-hours	After-hours	-	Pre-market	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	After-hours	Pre-market	Pre-market	-	-	-	-	-	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	After-hours	After-hours	Pre-market	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap1.96B

Enterprise Value891.01M

Trailing P/E11.75

Forward P/E19.61

Price / Sales1.40

Price / Book1.38

EPS4.35

Book Value36.85

Revenue (TTM)1.40B

Gross Profit (TTM)721.55M

EBITDA266.58M

Profit Margin11.97%

Operating Margin22.18%

Return on Equity13.44%

Return on Assets8.16%

Shares Outstanding38.40M

Shares Float14.69M

Beta0.31

Dividend Yield5.11%

Dividend Rate2.61

Payout Ratio59.97%

Dividends

20261×

2.61Jun 12, 2026

20251×

2.12Jun 16, 2025

20241×

1.28Jun 17, 2024

20231×

1.60Jun 15, 2023

20221×

1.50Jun 13, 2022

20211×

1.80Sep 7, 2021

20201×

1.80Jun 17, 2020

20191×

1.60Jul 8, 2019

20181×

2.10Jul 23, 2018

20171×

3.10Jul 25, 2017

20161×

2.10Jul 18, 2016

20151×

2.00Jul 20, 2015

20141×

2.80Aug 27, 2014

20131×

2.55Aug 28, 2013

20121×

2.40Aug 22, 2012

Stock Splits

Aug 28, 20131.1:1
Aug 22, 20121.1:1